These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
305 related items for PubMed ID: 20014427
1. Chemotherapy for gynecologic cancers. Rahaman J, Steiner N, Hayes MP, Chuang L, Fishman D, Gretz Iii H. Mt Sinai J Med; 2009 Dec; 76(6):577-88. PubMed ID: 20014427 [Abstract] [Full Text] [Related]
2. Current status of chemotherapy in gynecologic cancer. Tropé C, Kristensen G. Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-1-S15-22. PubMed ID: 9346216 [No Abstract] [Full Text] [Related]
5. New therapeutic approaches in gynecologic oncology. Kucera PR. Clin Lab Med; 1995 Sep; 15(3):743-70. PubMed ID: 8542732 [Abstract] [Full Text] [Related]
6. Recent updates in the clinical use of platinum compounds for the treatment of gynecologic cancers. Muggia FM. Semin Oncol; 2004 Dec; 31(6 Suppl 14):17-24. PubMed ID: 15726530 [Abstract] [Full Text] [Related]
7. The management of small-cell carcinomas of the gynecologic tract. Cohen JG, Chan JK, Kapp DS. Curr Opin Oncol; 2012 Sep; 24(5):572-9. PubMed ID: 22820410 [Abstract] [Full Text] [Related]
8. Adjuvant chemotherapy as treatment of high-risk stage I and II endometrial cancer. Aoki Y, Watanabe M, Amikura T, Obata H, Sekine M, Yahata T, Fujita K, Tanaka K. Gynecol Oncol; 2004 Aug; 94(2):333-9. PubMed ID: 15297170 [Abstract] [Full Text] [Related]
9. Ovarian cancer: a focus on management of recurrent disease. Herzog TJ, Pothuri B. Nat Clin Pract Oncol; 2006 Nov; 3(11):604-11. PubMed ID: 17080178 [Abstract] [Full Text] [Related]
10. [Clinical analysis of 42 cases of primary malignant melanoma in female genital tract]. An JS, Wu LY, Li N, Li B, Yu GZ, Liu LY. Zhonghua Fu Chan Ke Za Zhi; 2007 May; 42(5):320-4. PubMed ID: 17673044 [Abstract] [Full Text] [Related]
11. [Trends in comprehensive treatment for gynecologic malignancies]. Yakushiji M, Fujiyoshi K, Komai K, Imamura K. Gan To Kagaku Ryoho; 1999 Jun; 26 Suppl 1():145-56. PubMed ID: 10410669 [Abstract] [Full Text] [Related]
12. [Hormonal therapy and chemotherapy of endometrial cancer]. Krauss T, Huschmand H, Hinney B, Viereck V, Emons G. Zentralbl Gynakol; 2002 Jan; 124(1):45-50. PubMed ID: 11873314 [Abstract] [Full Text] [Related]
13. Management of advanced-stage and recurrent endometrial cancer. Ray M, Fleming G. Semin Oncol; 2009 Apr; 36(2):145-54. PubMed ID: 19332249 [Abstract] [Full Text] [Related]
15. [Decision-making of treatment and relative problems about recurrent and drug-resistant gynecologic neoplasms]. Xie X, Cheng XD. Zhonghua Fu Chan Ke Za Zhi; 2010 Nov; 45(11):801-3. PubMed ID: 21211274 [No Abstract] [Full Text] [Related]
16. Update on the management of ovarian cancer. Ozols RF. Cancer J; 2002 Nov; 8 Suppl 1():S22-30. PubMed ID: 12075699 [Abstract] [Full Text] [Related]
17. [Recurrent and 2nd line therapy in ovarian carcinoma: an overview of conventional systemic therapy modalities]. du Bois A, Lück HJ, Meerpohl HG. Zentralbl Gynakol; 1997 Nov; 119(7):299-323. PubMed ID: 9340970 [Abstract] [Full Text] [Related]
18. [Chemotherapy in the management of advanced or high risk cervical cancer]. Shimizu Y. Gan To Kagaku Ryoho; 1995 Aug; 22(9):1152-62. PubMed ID: 7661566 [Abstract] [Full Text] [Related]
19. Adjuvant therapy in gynecologic malignancies. Ovarian, cervical, and endometrial cancer. Curtin JP, Shapiro F. Surg Oncol Clin N Am; 1997 Oct; 6(4):813-30. PubMed ID: 9309095 [Abstract] [Full Text] [Related]